Fibrosis File -September-2015

    Fibrosis File Promedior is a biotechnology company developing medications to treat a range of fibrotic diseases. They have announced the beginning of the second phase of their PRM-151 clinical trial for those with Idiopathic Pulmonary Fibrosis (IPF). IPF causes lungs to become scarred, caus- ing irreversible loss of the tissue’s ability to transport…

The Oxygen Quiz -September-2015

    The Oxygen Quiz We are going to make you go back to school with this issue’s quiz – Respiratory School! Who discovered oxygen? What percentage of oxygen are you breathing in from room air? What is the approximate percentage of oxygen you are breathing when you are using oxygen at 1LPM? How does…

Difficult Life Decisions-July-2015

    Difficult Life Decisions Since it is a difficult subject to think about, end-of-life issues are discussed only 30 per- cent of the time when you are stable rather than during a crisis. When 8,000 people were surveyed, only 26 percent had written end- of-life plans. We want you to be prepared and document…

Pulmonary Fibrosis Foundation -July-2015

  Pulmonary Fibrosis Foundation The Pulmonary Fibrosis Foundation (PFF) will be celebrating Global Pulmonary Fibrosis Awareness Month in September and would like you to get involved – particularly on social media. If you have been touched by pulmonary fibrosis, the PFF says you have an important message to share. Hearing about what you are going…